$1.46+0.06 (+4.13%)
iHuman Inc.
iHuman Inc. in the Consumer Defensive sector is trading at $1.46 with a market capitalization of $74M. The stock is currently near its 52-week low of $1.33, remaining 27.5% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Total Revenue | $190.65Mβ | $205.76Mβ | $200.16Mβ | $210.44Mβ | $232.68M |
| Gross Profit | $127.46Mβ | $140.63Mβ | $135.75Mβ | $143.78Mβ | $156.44M |
| Operating Income | $9.00Mβ | $16.67Mβ | $19.49Mβ | $21.60Mβ | $14.92M |
| Net Income | $15.41Mβ | $21.59Mβ | $31.89Mβ | $26.52Mβ | $26.48M |
iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China and internationally. The company offers interactive and self-directed apps, including iHuman Chinese, iHuman...
The Middle Eastern stock markets have been experiencing mixed movements, with Saudi shares gaining while Qatar's market faces uncertainty due to geopolitical tensions. In such a climate, investors often turn to penny stocks as a way to explore potential growth opportunities in smaller or newer companies. Although the term "penny stocks" might seem outdated, these investments can still offer significant value when backed by strong financial health and fundamentals.
The Middle Eastern stock markets have recently experienced a downturn, with Gulf shares slipping amid geopolitical tensions and reports of potential US military action against Iran. Despite these challenges, the investment landscape in the region remains diverse and offers unique opportunities for investors willing to explore beyond traditional large-cap stocks. Penny stocks, though often seen as relics from earlier market days, continue to offer potential growth at lower price points when...
Key Insights Significant insider control over iHuman implies vested interests in company growth The largest shareholder...
Key Insights The projected fair value for iHuman is US$2.55 based on 2 Stage Free Cash Flow to Equity With US$2.56...
To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...